Travere Therapeutics, Inc.
Recent Filings
All 1,001 filings →| Form | Description | Date |
|---|---|---|
| SCHEDULE 13G/A | — | Mar 27, 2026 |
| 4 | — | Mar 18, 2026 |
| 144 | — | Mar 16, 2026 |
| 4 | — | Feb 24, 2026 |
| 144 | — | Feb 20, 2026 |
| 10-K | 10-K | Feb 19, 2026 |
| 4 | — | Feb 19, 2026 |
| 8-K | 8-K | Feb 19, 2026 |
| SCHEDULE 13G/A | — | Feb 17, 2026 |
| 144 | — | Feb 17, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Heerma Peter | CHIEF COMMERCIAL OFFICER | Sale | 4,980 @ $40.00 | 113,013 | Dec 24, 2025 |
| Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | Sale | 7,402 @ $40.00 | 38,233 | Dec 24, 2025 |
| Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | Sale | 2,910 @ $36.00 | 45,635 | Dec 15, 2025 |
| Heerma Peter | CHIEF COMMERCIAL OFFICER | Sale | 2,662 @ $30.00 | 124,662 | Oct 28, 2025 |
| Cline Christopher R. | CHIEF FINANCIAL OFFICER | Sale | 119 @ $19.71 | 92,083 | Sep 3, 2025 |
| Cline Christopher R. | CHIEF FINANCIAL OFFICER | Sale | 470 @ $17.31 | 92,656 | Aug 27, 2025 |
| Inrig Jula | CHIEF MEDICAL OFFICER | Sale | 815 @ $14.65 | 88,787 | Jul 1, 2025 |
| Williams Brinkley Ruth | — | Award / Grant | 6,500 | 25,750 | May 15, 2025 |
| Squarer Ron | — | Award / Grant | 6,500 | 35,375 | May 15, 2025 |
| Poole Sandra | — | Award / Grant | 6,500 | 30,000 | May 15, 2025 |